BUZZ-Neurocrine falls after analysts say forecast for key drug 'conservative'
Shares of drugmaker Neurocrine Biosciences NBIX.O decline about 15% to $128.54
Co forecasts sales of its drug Ingrezza in the range of $2.5 bln to $2.6 bln for 2025, in line with analysts' expectations of $2.55 bln - according to LSEG data
Ingrezza is approved for treating involuntary movements in the face, tongue, or other body parts related to Huntington's disease, a genetic brain disorder
At least two brokerages said that forecast for Ingrezza, NBIX's only drug on the market, was conservative
"Conservative Ingrezza guidance can be due to competition pressure" - Brokerage H.C. Wainwright, referring to rival drug Austedo from Teva Pharmaceuticals TEVA.N
Worse-than-expected forecast may show slowing of growth for Neurocrine's most consistent drug - BMO Capital Markets
Co posted Q4 total sales of $627.7 mln, below analyst est of $629 mln- LSEG data
In 2024, NBIX rose 3%
Related Articles
National Debt Bomb Ignited? Musk Warns U.S. Will Be 1000% Bankrupt Without AI
TradingKey - Tesla (TSLA) CEO Elon Musk recently issued another warning regarding the rapidly ballooning U.S. national debt. He stated clearly that without artificial intelligence and robotics, the United States will inevitably head toward fiscal bankruptcy.
Tesla Stock Outlook: Competing With Rivian, Robotaxi Potential, and 2026 Prospects
There is much conversation about the prospect of investing in Tesla (TSLA) as we move closer to 2026. The volatility of its share price in 2025 is leading many investors to consider if they should purchase shares of Tesla given the alternatives available in terms of electric vehicles (Rivian, etc.).
Why Sanae Takaichi Winning Japan’s Diet Election Led to a Surge in Japanese Stock Indices？
TradingKey - Reports indicate that the ruling coalition led by Japanese Prime Minister Sanae Takaichi has secured a single-party majority in the parliamentary elections held on Sunday (February 8). Following the news, the yen weakened slightly, while the Nikkei Index surpassed 57,000 for the first t
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
